Guidelines

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

Department of Pediatric Hematology/Oncology, Erasmus Medical Center, Sophia Children’s Hospital, Rotterdam, The Netherlands
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children’s Hospital, MA, USA
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Department of Pediatric Hematology, Hôpital Robert Debré, Paris and University Paris Diderot, France
University Medical Centre Hamburg-Eppendorf, Clinic of Paediatric Hematology and Oncology, Hamburg, Germany
Great Ormond Street Hospital, London, UK
Pediatric Hematology/Oncology and Stem cell transplantation, Ghent University Hospital, Belgium
Department of Pediatric Hematology/Oncology, University Hospital Vall d’Hebron, Barcelona, Spain
Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, Hospital S. Gerardo, Monza
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children’s Hospital, MA, USA
Division of Haematology/Oncology, The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Ontario, Canada
Vol. 101 No. 3 (2016): March, 2016 https://doi.org/10.3324/haematol.2015.137380